Skip to main content
Equibles
ARTV logo

ARTV · Artiva Biotherapeutics, Inc.

Track ARTV — free

Use ARTV with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ARTV

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$11.77 +0.25 (+2.17%) At close · Aug 25
Market Cap
$579.35M
Shares
48.89M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

ARTV Short Interest Forecast

Equibles' model estimates 2,023,211 shares sold short for the August 31, 2026 settlement, -3.5% versus the latest reported position. This model prediction uses FINRA data through August 21, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 21
2,023,211 -3.5% vs reported
The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
74/100
Short interest 4.3% of shares — P69 Days to cover 6.1 — P77 Price vs VWAP +25.2% — P94 Short-volume trend +3.1% — P63 Short interest change +9.1% — P75 Worst FTD 0.03% of shares — P67

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-09-15 Scheduled
    FINRA publishes Sep 24
    		 — — — —
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 2,095,813 1,921,843 +173,970 6.07
    2026-07-31 1,921,843 1,724,074 +197,769 5.13
    2026-07-15 1,724,074 1,339,927 +384,147 3.77
    2026-06-30 1,339,927 1,079,519 +260,408 1.82
    2026-06-15 1,079,519 1,025,413 +54,106 1.63
    2026-05-29 1,025,413 480,610 +544,803 1.98
    2026-05-15 480,579 229,817 +250,762 1.00
    2026-04-30 229,817 148,487 +81,330 1.00
    2026-04-15 148,487 148,199 +288 1.00
    2026-03-31 148,199 147,133 +1,066 1.18
    2026-03-13 147,133 148,835 -1,702 1.00
    2026-02-27 148,835 189,121 -40,286 1.15
    2026-02-13 189,121 203,792 -14,671 1.37
    2026-01-30 203,792 284,944 -81,152 1.02
    2026-01-15 284,944 391,100 -106,156 1.19
    2025-12-31 391,100 178,188 +212,912 1.00
    2025-12-15 178,188 160,433 +17,755 1.00
    2025-11-28 160,433 221,279 -60,846 1.34
    2025-11-14 221,279 256,977 -35,698 1.00
    2025-10-31 256,977 203,790 +53,187 1.00
    2025-10-15 203,790 227,734 -23,944 6.81
    2025-09-30 227,734 290,934 -63,200 1.67
    2025-09-15 290,934 305,010 -14,076 3.40
    2025-08-29 305,010 304,476 +534 4.80
    Showing 1–24 of 24 settlements
    Key facts CIK 1817241 CUSIP 04317A107 13F (30d) 72 filings 72 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)